🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mortality and Muscle Mass Loss in Critically Ill Patients.

Recruitingn/aAges 18 Years - anyAllBrno University Hospital
NCT07280039 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to monitor changes in muscle mass in critically ill patients and to verify whether a decrease in muscle mass of ≥10% during the first 7 days of hospitalization is associated with increased 28-day mortality. We will be used ultrasound for measurement the rectus femoris cross sectional area.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * age ≥18 years * mechanical ventilation expected for at least 48 hours Exclusion Criteria: * Clinical Frailty Score above 7 prior admission * Neuromuscular disease in previous medical history * Amputated lower extremities * Trauma of lower extremities involving tights * Conditions affecting the nervous system with involvement of the thigh muscle * Inability to cooperate during ultrasound examination * Inability to perform ultrasound examination on day 7 9\. Inability to perform ultrasound examination on day 7
💊

What it tests

  • Not listed
📍

Where

1 site
The University Hospital Brno
Brno, Czechia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy